- Home
- Media
- Press Releases
Press Releases
Julphar successfully concludes Phase I clinical trial of its biosimilar human insulin
2015-04-29
Julphar today announced its Phase 1 clinical data that demonstrated similarity of its investigational biosimilar human insulin compared to the EU-licensed reference product, Eli Lilly HUMINSULIN®.…
Julphar announces AED 1.4 billion in sales for 2014
2015-02-23
Profit grows to AED 235 million, showing steady growth for the Emirati company. Julphar held a Board of Directors meeting at their RAK Head Office to announce a draft financial report, registering sales…
Julphar strengthens asset base amid UAE pharmaceuticals push
2015-02-22
The UAE drug maker Julphar increased the value of its assets last year as the government pushes for more home-grown manufacturing of medicine. The manufacturer of generic medicines now has assets worth…
Julphar buys majority stake In Bangladesh-based RAK Pharmaceuticals
2015-02-10
UAE pharmaceuticals firm Julphar has acquired a majority stake in Bangladesh-based RAK Pharmaceuticals, for a consideration of $9.5 million. The deal marks Julphar’s entry into the Bangladeshi market…